Ming is a consultant at Catalyze, where her role is to support clients in raising funds to finance the further development of their innovations. Ming works with clients to shape their ideas into coherent project concepts, and in turn formats these concepts into compelling and competitive subsidy proposals and business plans. For every project, Ming particularly focuses on strategic positioning, route-to-market/clinic strategies, and on identifying and highlighting the specific uniqueness of the innovation in question. As a former researcher herself, what Ming enjoys most about her role is the interaction with bright, innovative minds, and what brings her energy is the opportunity to support the expedition of new innovations through development towards market entry. Ming has particular expertise in projects focused on drug development, medical devices (development and commercialization) and those that have substantial association with Chemistry.
Ming obtained her PhD from Imperial College London, where she worked on developing non-viral vectors for gene therapy. Prior to becoming a consultant, Ming was a scientist at the pharmaceutical company, BioMarin, and prior to that she held postdoctoral positions at the University of Illinois and at the University of Tokyo.